Vanda Pharmaceuticals Company Profile News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vanda pharmaceuticals company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vanda Pharmaceuticals Company Profile Today - Breaking & Trending Today

Vanda Pharmaceuticals (NASDAQ:VNDA) Lifted to Buy at StockNews.com

StockNews.com upgraded shares of Vanda Pharmaceuticals (NASDAQ:VNDA – Free Report) from a hold rating to a buy rating in a report issued on Thursday. Vanda Pharmaceuticals Stock Performance Vanda Pharmaceuticals stock opened at $3.76 on Thursday. The firm has a market cap of $216.31 million, a price-to-earnings ratio of 17.91 and a beta of 0.59. […] ....

Lido Advisors , Sherbrooke Park Advisers , Tower Research Capital , Quadrant Capital Group , Vanda Pharmaceuticals , Vanda Pharmaceuticals Inc , Vanda Pharmaceuticals Company Profile , Vanda Pharmaceuticals Stock Performance , News Ratings For Vanda Pharmaceuticals Daily , Free Report , Capital Group , Research Capital , Get Free Report , Pharmaceuticals Inc , Vanda Pharmaceuticals Daily , Nasdaq Vnda , Stocknews Com ,

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Short Interest Update

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Get Free Report) was the target of a large decline in short interest in September. As of September 30th, there was short interest totalling 1,510,000 shares, a decline of 64.1% from the September 15th total of 4,210,000 shares. Currently, 3.1% of the company’s stock are short sold. Based on an […] ....

Stephen Ray Mitchell , Vanda Pharmaceuticals Company Profile , Renaissance Technologies , Vanda Pharmaceuticals , Securities Exchange Commission , Hedge Funds Weigh In On Vanda Pharmaceuticals , News Ratings For Vanda Pharmaceuticals Daily , Vanda Pharmaceuticals Stock Performance , Dimensional Fund Advisors , Vanguard Group Inc , Blackrock Inc , Vanda Pharmaceuticals Inc , Get Free Report , Director Stephen Ray Mitchell , Exchange Commission , Street Corp , Fund Advisors , Pharmaceuticals Inc , Vanda Pharmaceuticals Daily , Nasdaq Vnda ,